Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€40.88
03.04.22
-
03.04.23
39.43%
04.04.23

Could be worthwhile Investment >10% per year
Lokrim 
03.04.22 20%
buy
BeiGene Ltd ADR

Start price
Target price
Perf. (%)
€184.00
02.04.22
€200.00
02.04.23
-15.22%
16.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
skatcup 
02.04.22 50%
buy
Carmat

Start price
Target price
Perf. (%)
€14.84
30.03.22
€18.00
30.03.23
-17.45%
22.10.22

Could be worthwhile Investment >10% per year
melinda 
30.03.22 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.60
30.03.22
-
30.03.23
-55.74%
20.11.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
30.03.22 0%
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€8.06
29.03.22
€15.30
29.03.23
-17.24%
30.03.23

Could be worthwhile Investment >10% per year
melinda 
29.03.22 50%
buy
iRhythm Technologies Inc

Start price
Target price
Perf. (%)
€137.00
29.03.22
-
29.03.23
-16.79%
29.03.23

Saftman 
29.03.22 50%
buy
Evolent Health Inc

Start price
Target price
Perf. (%)
€28.40
29.03.22
-
29.03.23
-0.70%
29.03.23

Saftman 
29.03.22 50%
buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€25.40
28.03.22
-
28.03.23
25.20%
02.04.22

Risky Investment
Global_Player 
28.03.22 50%
sell
Palisade Bio Inc.

Start price
Target price
Perf. (%)
€59.50
22.03.22
-
22.03.23
-20.59%
31.03.22

Risky Investment
Global_Player 
22.03.22 50%
buy
Agenus Inc.

Start price
Target price
Perf. (%)
€2.54
22.03.22
-
22.03.23
-42.13%
21.05.22

Lector 
22.03.22 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€64.50
22.03.22
-
22.03.23
-43.57%
23.03.23

Saftman 
22.03.22 50%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€7.65
21.03.22
€11.00
21.03.23
-7.01%
22.03.23

Could be worthwhile Investment >10% per year
Higher risks for its business
tbackenh 
21.03.22 50%
sell
Bovie Medical Corp

Start price
Target price
Perf. (%)
€6.45
20.03.22
-
20.03.23
-8.53%
28.05.22

Risky Investment
Lokrim 
20.03.22 20%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€21.29
16.03.22
€56.00
16.03.23
149.27%
17.03.23

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
16.03.22 60%
sell
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€81.03
15.03.22
-
15.03.23
-14.84%
20.03.22

Could be worthwhile Investment >10% per year
Vassago1 
15.03.22 50%
sell
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€20.53
14.03.22
€14.00
14.03.23
3.70%
16.03.22

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
geldnutzer 
14.03.22 60%
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.81
14.03.22
€6.40
14.03.23
-33.68%
11.06.22

Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
geldnutzer 
14.03.22 50%
buy
Mediclin AG

Start price
Target price
Perf. (%)
€3.32
07.03.22
-
07.03.23
0.60%
19.03.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
kostojunior 
07.03.22 60%
sell
Innate Pharma

Start price
Target price
Perf. (%)
€2.51
07.03.22
-
07.03.23
21.39%
08.03.23

Probably not worthwhile Investment
Lokrim 
07.03.22 20%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.96
07.03.22
-
07.03.23
27.52%
28.03.22

Could be worthwhile Investment >10% per year
robertinio 
07.03.22 100%
buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€14.57
01.03.22
-
01.03.23
-43.77%
02.03.23

Saftman 
01.03.22 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.14
26.02.22
-
26.02.23
-59.29%
27.10.22

Could be very worthwhile Investment >20% year
ngapali 
26.02.22 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.79
22.02.22
€4.00
22.02.23
-45.05%
23.02.23

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
MoneyMoney 
22.02.22 0%
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.03
22.02.22
€1.00
22.02.23
-25.24%
05.03.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
me8 
22.02.22 0%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.71
22.02.22
€5.00
22.02.23
18.89%
23.02.22

Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
me8 
22.02.22 0%